HEARTFLOW, INC.
MOUNTAIN VIEW, CA

HeartFlow, Inc. is a pioneering company dedicated to advancing cardiovascular health analysis using cutting-edge protocols and secure data management technologies at every stage of its processes. The organization specializes in transmitting cardiac CT images securely for robust heart flow analysis, delivering results through a fortified interface to medical professionals. HeartFlow’s state-of-the-art platform assists clinicians by providing in-depth insights into patients’ heart conditions, complementing other diagnostic information available. This comprehensive data helps healthcare providers make informed decisions about treatment and management strategies. HeartFlow is incorporated under the status Florida.Models.Dos.FloridaCompanyStatus with its headquarters located at 331 E. Evelyn Avenue, Mountain View, CA. Despite being headquartered in California, it has ties to DE as its home state designation and Broward County for company registration. It filed as a For-Profit Corporation (FORP) with the Filing Number: F17000005073, officially registered on November 9, 2017. The organization is guided by prominent leaders including John Stevens as Chief Executive Officer, Campbell Rogers as CMO (assuming "Chie" implies Chief Medical Officer), and William Weldon serving as CAO (likely implying Chief Administrative Officer). HeartFlow’s commitment to product support ensures reliable access to necessary assistance for both providers and patients. For additional details regarding product indications and the limitations of analyses performed by HeartFlow, stakeholders are encouraged to consult their official resources. The company maintains transparent communication with its clientele through several contact channels including (650) 241-1221, (650) 241-0500, and a dedicated support line at (844) 443-8378. Prospective clients or partners can explore more about HeartFlow's innovative solutions on their website, heartflow.com. The last annual report was filed on April 15, 2024, marking the year as one that continues to see growth and advancements in cardiac health analysis.